Friday, July 24, 2026

Blackstone fund to invest ₹1,800 crore in Kolte-Patil; its first bet on residential real estate

Date:

Blackstone Group, one of the world’s largest alternative investment firms, will invest ₹1,800 crore in Kolte-Patil Developers. This will be Blackstone’s first bet on residential real estate.Blackstone will acquire a 14.3% stake in Kolte Patil Developers through a preferential allotment route. The acquisition will be conducted via BREP Asia III India Holding Co, which is a Blackstone entity.

Additionally, Blackstone has announced an open offer to acquire a 26% stake in the Pune-based real estate firm.Under the agreement, BREP Asia III India Holding Co will subscribe to 1.26 crore equity shares of Kolte Patil Developers. Each share, with a face value of Rs 10, will be issued at a price of Rs 329 per share. The price of Rs 329 per share to Blackstone is at a 2.6% discount to the current market price. The company will raise Rs 417 crore through the preferential issue.

Upon completion of the preferential allotment and the subsequent acquisition of shares from existing stakeholders, BREP Asia III India Holding Co will be classified as a promoter of Kolte Patil Developers.

This move will give Blackstone joint control of the company alongside its existing promoters.

Shares of Kolte-Patil Developers Ltd. are currently trading 1.58% lower on Thursday at 333.40.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Planning to invest in a bond SIP? Why it doesn’t work like your regular equity SIP

लाइवमिंटलगभग एक दशक से, लाइवमिंट-न्यूज़ डेस्क प्रामाणिक और सामयिक...

India condemns attack on commercial vessel in Black Sea; one Indian crew member killed

India on Friday condemned the attack on the commercial...

CSB Bank Q1 Results: Stock falls 7% after asset quality deteriorates, provisions rise

Shares of CSB Bank Ltd., the Thrissur-based private lender,...

Eli Lilly-backed Scribe Therapeutics climbs 67% after raising $128.7 million in an upsized IPO

हृदय रोगों के लिए जीन थेरेपी के क्लिनिकल-स्टेज डेवलपर,...